1.
Eksp Klin Gastroenterol
; (2): 29-35, 2005.
Article
in Russian
| MEDLINE
| ID: mdl-15932152
Subject(s)
Benzimidazoles/adverse effects , Benzimidazoles/therapeutic use , Enzyme Inhibitors/therapeutic use , Gastroesophageal Reflux/drug therapy , Omeprazole/analogs & derivatives , Omeprazole/adverse effects , Omeprazole/therapeutic use , Proton-Translocating ATPases/antagonists & inhibitors , 2-Pyridinylmethylsulfinylbenzimidazoles , Adult , Aged , Female , Humans , Male , Middle Aged , Rabeprazole , Treatment Outcome
2.
Eksp Klin Gastroenterol
; (5): 53-5, 2005.
Article
in Russian
| MEDLINE
| ID: mdl-16518916
Subject(s)
Dyspepsia/drug therapy , Histamine H2 Antagonists/therapeutic use , Ranitidine/therapeutic use , Adult , Aged , Female , Humans , Male , Middle Aged , Syndrome , Treatment Outcome
3.
Eksp Klin Gastroenterol
; (3): 45-8, 104, 2004.
Article
in Russian
| MEDLINE
| ID: mdl-15560401
ABSTRACT
At present proton pump inhibitors have been the most efficient drugs for treating the gastroesophageal reflux disease (GERD). Pariet may be selected as a drug for treating all forms of GERD as it requires smaller doses and shorter treatment period to obtain the clinical and endoscopic remission. Upon the clinical and endoscopic remission, patients need a supportive treatment. Different patients need various supportive treatment schemes. Our goal comes to the provision of the maximum efficiency of the schemes when prescribing the minimum doses of the drug.